Vitasora Health Company Description

Vitasora Health Limited engages in the research, development, and commercialization of medical devices in Australia and the United States.

The company offers wheezo device. It is also involved in the production of mobile health applications.

In addition, the company provides solutions for managing chronic diseases, including cardiovascular, diabetes, chronic obstructive pulmonary disease, and obesity.

The company was formerly known as Respiri Limited and changed its name to Vitasora Health Limited in April 2025.

The company is headquartered in Melbourne, Australia.

Vitasora Health Limited

Country	Australia
Founded	1987
Industry	Health Information Services
Sector	Healthcare
Employees	30
CEO	Marjan Mikel

Contact Details

Address: 432 St Kilda Road Melbourne, VIC 3004 Australia
Phone	61 3 9653 9160
Website	vitasorahealth.com.au

Stock Details

Ticker Symbol	VHL
Exchange	Australian Securities Exchange
Fiscal Year	July - June
Reporting Currency	AUD
ISIN Number	AU0000392748
SIC Code	3845

Key Executives

Name	Position
Marjan Mikel B.Sc., M.A.I.C.D.	Chief Executive Officer, MD and Executive Director
Nicholas Smedley	Executive Chairman
Peter Hildebrandt	Chief Operations Officer
Dr. Samaneh Sarraf Shirazi	Chief Research Officer
William Sigsbee	Head of US Operations and Chief Commercial Officer for the US market
Tony Di Pietro	Company Secretary
Prof. Noam Gavriely D.Sc., M.D.	Medical and Scientific Advisor
Simon Godfrey FRCP, FRCPCH, M.D., Ph.D.	Medical and Scientific Advisor